Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin for peripheral perfusion abnormalities in circulatory shock
NL-OMON44686Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nitroglycerin in Shock (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Capillary refill time, Skin-difference temperature gradient and 6 more. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
nitroglycerin
03
Conditions
Shock
Beyond the preview
Go deeper on NL-OMON44686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44686.